David M. Geller

3.2k total citations · 2 hit papers
24 papers, 2.8k citations indexed

About

David M. Geller is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, David M. Geller has authored 24 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 3 papers in Cellular and Molecular Neuroscience and 3 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in David M. Geller's work include Receptor Mechanisms and Signaling (7 papers), Chemical Synthesis and Analysis (4 papers) and Protein purification and stability (3 papers). David M. Geller is often cited by papers focused on Receptor Mechanisms and Signaling (7 papers), Chemical Synthesis and Analysis (4 papers) and Protein purification and stability (3 papers). David M. Geller collaborates with scholars based in United States, United Kingdom and Japan. David M. Geller's co-authors include Philip Needleman, Mark G. Currie, Barbara R. Cole, Kam F. Fok, Ned R. Siegel, David Schwartz, Clifford B. Saper, S W Holmberg, David G. Standaert and Shad R. Eubanks and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

David M. Geller

24 papers receiving 2.5k citations

Hit Papers

Bioactive Cardiac Substances: Potent Vasorelaxant Activit... 1983 2026 1997 2011 1983 1984 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David M. Geller United States 18 1.5k 1.3k 445 368 213 24 2.8k
Philip A. Khairallah United States 25 1.0k 0.7× 1.0k 0.8× 400 0.9× 141 0.4× 379 1.8× 75 2.4k
Raymond J. Winquist United States 27 1.2k 0.8× 1.4k 1.1× 476 1.1× 240 0.7× 161 0.8× 69 2.9k
Yoshiaki Masuda Japan 24 1.0k 0.7× 880 0.7× 237 0.5× 401 1.1× 113 0.5× 98 2.2k
Ingrid L. Grupp United States 38 2.7k 1.8× 2.9k 2.2× 586 1.3× 120 0.3× 174 0.8× 63 4.2k
A. Löwenthal Belgium 30 450 0.3× 803 0.6× 259 0.6× 260 0.7× 92 0.4× 147 2.7k
Brian D. Guth Germany 32 1.9k 1.3× 779 0.6× 284 0.6× 99 0.3× 215 1.0× 103 3.3k
Ruth A. Altschuld United States 41 2.4k 1.6× 3.1k 2.4× 1.0k 2.4× 105 0.3× 107 0.5× 106 5.1k
Howard S. Silverman United States 27 1.2k 0.8× 1.8k 1.4× 431 1.0× 88 0.2× 66 0.3× 44 3.0k
E. J. Cragoe United States 31 340 0.2× 1.8k 1.3× 446 1.0× 204 0.6× 95 0.4× 77 2.7k
Matthew A. Movsesian United States 35 2.0k 1.3× 2.7k 2.1× 284 0.6× 178 0.5× 81 0.4× 72 4.0k

Countries citing papers authored by David M. Geller

Since Specialization
Citations

This map shows the geographic impact of David M. Geller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David M. Geller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David M. Geller more than expected).

Fields of papers citing papers by David M. Geller

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David M. Geller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David M. Geller. The network helps show where David M. Geller may publish in the future.

Co-authorship network of co-authors of David M. Geller

This figure shows the co-authorship network connecting the top 25 collaborators of David M. Geller. A scholar is included among the top collaborators of David M. Geller based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David M. Geller. David M. Geller is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Geller, David M., et al.. (1986). Identification of the cardiac and circulating form of atriopeptin in rabbit. Biochemical and Biophysical Research Communications. 138(3). 1263–1268. 9 indexed citations
2.
Needleman, Philip, S P Adams, Barbara R. Cole, et al.. (1985). Atriopeptins as cardiac hormones.. Hypertension. 7(4). 469–482. 341 indexed citations
3.
Schwartz, David, David M. Geller, Pamela T. Manning, et al.. (1985). Ser-Leu-Arg-Arg-Atriopeptin III: The Major Circulating Form of Atrial Peptide. Science. 229(4711). 397–400. 271 indexed citations
4.
Wakitani, K., Barbara R. Cole, David M. Geller, et al.. (1985). Atriopeptins: correlation between renal vasodilation and natriuresis. American Journal of Physiology-Renal Physiology. 249(1). F49–F53. 42 indexed citations
5.
Saper, Clifford B., David G. Standaert, Mark G. Currie, et al.. (1985). Atriopeptin-Immunoreactive Neurons in the Brain: Presence in Cardiovascular Regulatory Areas. Science. 227(4690). 1047–1049. 315 indexed citations
6.
Needleman, Philip, Mark G. Currie, David M. Geller, Barbara R. Cole, & Steven P. Adams. (1984). Atriopeptins: potential mediators of an endocrine relationship between heart and kidney. Trends in Pharmacological Sciences. 5. 506–509. 40 indexed citations
7.
Currie, Mark G., David M. Geller, Julie Chao, Harry S. Margolius, & Philip Needleman. (1984). Kallikrein activation of a high molecular weight atrial peptide. Biochemical and Biophysical Research Communications. 120(2). 461–466. 48 indexed citations
8.
Currie, Mark G., David M. Geller, Barbara R. Cole, & Philip Needleman. (1984). Proteolytic activation of a bioactive cardiac peptide by in vitro trypsin cleavage.. Proceedings of the National Academy of Sciences. 81(4). 1230–1233. 25 indexed citations
9.
Oshima, Takeshi, Mark G. Currie, David M. Geller, & Philip Needleman. (1984). An atrial peptide is a potent renal vasodilator substance.. Circulation Research. 54(5). 612–616. 106 indexed citations
10.
Currie, Mark G., David M. Geller, Barbara R. Cole, et al.. (1984). Purification and Sequence Analysis of Bioactive Atrial Peptides (Atriopeptins). Science. 223(4631). 67–69. 460 indexed citations breakdown →
11.
Currie, Mark G., et al.. (1983). Bioactive Cardiac Substances: Potent Vasorelaxant Activity in Mammalian Atria. Science. 221(4605). 71–73. 629 indexed citations breakdown →
12.
Schmidt, Robert E., David M. Geller, & Eugene M. Johnson. (1981). Characterization of Increased Plasma Dopamine-β-Hydroxylase Activity in Rats with Experimental Diabetes. Diabetes. 30(5). 416–423. 10 indexed citations
13.
Rosen, Arnold & David M. Geller. (1977). Chicken microsomal albumin: Amino terminal sequence of chicken proalbumin. Biochemical and Biophysical Research Communications. 78(3). 1060–1066. 19 indexed citations
14.
Russell, John H. & David M. Geller. (1973). Rat serum albumin biosynthesis: Evidence for a precursor. Biochemical and Biophysical Research Communications. 55(1). 239–245. 37 indexed citations
15.
Geller, David M.. (1972). [6] ATP formation. Methods in enzymology on CD-ROM/Methods in enzymology. 24. 88–92. 1 indexed citations
16.
Geller, David M., et al.. (1972). Intracellular distribution of serum albumin and its possible precursors in rat liver. Biochemical Journal. 127(5). 865–874. 52 indexed citations
18.
Geller, David M.. (1967). Correlation of Light-induced Absorbance Changes with Photophosphorylation in Rhodospirillum rubrum Extracts. Journal of Biological Chemistry. 242(1). 40–46. 10 indexed citations
19.
Geller, David M.. (1966). Kinetics of light-induced absorbance changes in Rhodospirillum rubrum extracts. Biochemical and Biophysical Research Communications. 23(4). 415–421. 3 indexed citations
20.
Geller, David M.. (1962). Oxidative Phosphorylation in Extracts of Rhodospirillum rubrum. Journal of Biological Chemistry. 237(9). 2947–2954. 47 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026